Nursing facility
Consolidated Resources Health Care Fund I, LP
Consolidated Resources Health Care Fund I, LP was paid $74K by Medicaid between Oct 2018 and Dec 2020, across 37 billing codes. Its largest line is 97530, Therapeutic activities, direct patient contact, each 15 minutes — 16% of everything it billed.
33Billing provider infoCONSOLIDATED RESOURCES HEALTH CARE FUND I, LP
FEDERAL WAY, WA 98003
FEDERAL WAY, WA 98003
33aNPI1881648061assigned 05/20/2006
33bProvider typeSkilled Nursing Facility
28Total paid$74K
24GClaims3,751
24DCodes billed37
24AFirst – last monthOct 2018 – Dec 2020
Compared with peers
Next to other Skilled Nursing Facility providers in Washington
Rank by total paid#9 of 98
Median peer was paid$921.10
This provider vs. median80×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official CROSS, CINDY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 492 | $785.73 | |
| 2019 | 867 | $7K | |
| 2020 | 2,392 | $66K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 16% | 1,560 | 213 | $12K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 16% | 1,010 | 141 | $12K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 15% | 102 | 99 | $11K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9.0% | 13 | 13 | $7K |
| 96361 | Intravenous infusion, hydration; each additional hour | 8.7% | 20 | 19 | $6K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.7% | 37 | 37 | $6K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 7.2% | 40 | 40 | $5K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.6% | 38 | 38 | $5K |
| 80053 | Comprehensive metabolic panel | 2.3% | 108 | 105 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.0% | 16 | 16 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 124 | 124 | $925.72 |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 156 | 33 | $736.56 |
25 more codes
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 23 | $722.69 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 32 | $576.64 |
| 36415 | Collection of venous blood by venipuncture | <1% | 90 | $496.92 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 16 | $439.05 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 19 | $382.44 |
| 71045 | Radiologic examination, chest; single view | <1% | 17 | $373.72 |
| 84484 | <1% | 18 | $345.57 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 20 | $262.87 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 14 | $248.51 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 15 | $248.51 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 13 | $228.05 |
| 83690 | <1% | 18 | $179.43 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 21 | $140.30 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 14 | $93.65 |
| 83735 | <1% | 15 | $81.71 | |
| 85610 | <1% | 15 | $72.58 | |
| 81025 | <1% | 17 | $66.12 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 16 | $34.94 |
| 81001 | <1% | 30 | $31.35 | |
| 81003 | <1% | 13 | $27.24 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 23 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 13 | $0.00 |
| G8982 | Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 21 | $0.00 |
| G8981 | Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 16 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCROSS, CINDY (ASSISTANT SECRETARY)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.